PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,960,595 | -15.2% | 228,408 | -11.4% | 0.00% | 0.0% |
| Q2 2023 | $4,669,234 | -78.4% | 257,684 | -68.3% | 0.00% | -80.0% |
| Q1 2023 | $21,633,009 | +92.6% | 813,271 | +40.0% | 0.01% | +150.0% |
| Q4 2022 | $11,232,586 | +157.0% | 581,096 | +177.8% | 0.00% | +100.0% |
| Q3 2022 | $4,370,000 | +193.3% | 209,197 | +12.5% | 0.00% | – |
| Q2 2022 | $1,490,000 | -43.8% | 185,892 | -5.4% | 0.00% | – |
| Q4 2021 | $2,652,000 | +211.6% | 196,406 | +289.3% | 0.00% | – |
| Q3 2021 | $851,000 | +319.2% | 50,448 | +624.9% | 0.00% | – |
| Q2 2021 | $203,000 | -79.8% | 6,959 | -72.8% | 0.00% | – |
| Q1 2021 | $1,007,000 | +52.1% | 25,598 | -12.1% | 0.00% | – |
| Q4 2020 | $662,000 | -22.4% | 29,108 | -22.7% | 0.00% | – |
| Q3 2020 | $853,000 | – | 37,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |